{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T03:59:42Z","timestamp":1780545582620,"version":"3.54.1"},"reference-count":69,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.cld.2022.08.005","type":"journal-article","created":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T04:33:48Z","timestamp":1666067628000},"page":"157-172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Alcohol-Related Liver Disease Including New Developments"],"prefix":"10.1016","volume":"27","author":[{"given":"Parita Virendra","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven L.","family":"Flamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cld.2022.08.005_bib1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cld.2018.09.011","article-title":"Epidemiology of alcohol consumption and societal burden of alcoholism and alcoholic liver disease","volume":"23","author":"Axley","year":"2019","journal-title":"Clin Liver Dis"},{"issue":"6","key":"10.1016\/j.cld.2022.08.005_bib2","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/add.13757","article-title":"The relationship between different dimensions of alcohol use and the burden of disease-an update","volume":"112","author":"Rehm","year":"2017","journal-title":"Addict"},{"issue":"9","key":"10.1016\/j.cld.2022.08.005_bib3","doi-asserted-by":"crossref","first-page":"eaax4043","DOI":"10.1126\/sciadv.aax4043","article-title":"Advances in the science and treatment of alcohol use disorder","volume":"5","author":"Witkiewitz","year":"2019","journal-title":"Sci Adv"},{"issue":"5","key":"10.1016\/j.cld.2022.08.005_bib4","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/j.amepre.2015.05.031","article-title":"2010 National and state costs of excessive alcohol consumption","volume":"49","author":"Sacks","year":"2015","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.cld.2022.08.005_bib5","unstructured":"Organization WH. Global Status Report on Alcohol and Health 2018. 2018. Available at: https:\/\/www.who.int\/publications\/i\/item\/9789241565639."},{"issue":"8","key":"10.1016\/j.cld.2022.08.005_bib6","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/jamapsychiatry.2015.0584","article-title":"Epidemiology of DSM-5 alcohol use disorder: results from the national epidemiologic survey on alcohol and related conditions III","volume":"72","author":"Grant","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.cld.2022.08.005_bib7","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.30866","article-title":"Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American association for the study of liver diseases","volume":"71","author":"Crabb","year":"2020","journal-title":"Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2022.08.005_bib8","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1053\/j.gastro.2011.09.002","article-title":"Alcoholic liver disease: pathogenesis and new therapeutic targets","volume":"141","author":"Gao","year":"2011","journal-title":"Gastroenterol"},{"key":"10.1016\/j.cld.2022.08.005_bib9","doi-asserted-by":"crossref","first-page":"k2817","DOI":"10.1136\/bmj.k2817","article-title":"Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study","volume":"362","author":"Tapper","year":"2018","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.cld.2022.08.005_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines7040099","article-title":"Global burden of alcohol use disorders and alcohol liver disease","volume":"7","author":"Rehm","year":"2019","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.cld.2022.08.005_bib11","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10620-013-2942-0","article-title":"Consequences of perceived stigma among patients with cirrhosis","volume":"59","author":"Vaughn-Sandler","year":"2014","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.cld.2022.08.005_bib12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cld.2018.09.004","article-title":"Alcohol use disorders in alcoholic liver disease","volume":"23","author":"Mellinger","year":"2019","journal-title":"Clin Liver Dis"},{"issue":"7","key":"10.1016\/j.cld.2022.08.005_bib13","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s11606-009-0928-6","article-title":"Primary care validation of a single-question alcohol screening test","volume":"24","author":"Smith","year":"2009","journal-title":"J\u00a0Gen Intern Med"},{"issue":"6","key":"10.1016\/j.cld.2022.08.005_bib14","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","article-title":"Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption--II","volume":"88","author":"Saunders","year":"1993","journal-title":"Addict"},{"issue":"7","key":"10.1016\/j.cld.2022.08.005_bib15","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/j.1530-0277.2007.00403.x","article-title":"AUDIT-C as a brief screen for alcohol misuse in primary care","volume":"31","author":"Bradley","year":"2007","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"10.1016\/j.cld.2022.08.005_bib16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/acer.13276","article-title":"Follow-up of alcohol consumption after liver transplantation: interest of an addiction team?","volume":"41","author":"Donnadieu-Rigole","year":"2017","journal-title":"Alcohol Clin Exp Res"},{"issue":"2","key":"10.1016\/j.cld.2022.08.005_bib17","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/acer.13944","article-title":"Gender Disparities in alcohol use disorder treatment among privately insured patients with alcohol-associated cirrhosis","volume":"43","author":"Mellinger","year":"2019","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.cld.2022.08.005_bib18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.yrtph.2018.01.029","article-title":"Providing context for phosphatidylethanol as a biomarker of alcohol consumption with a pharmacokinetic model","volume":"94","author":"Simon","year":"2018","journal-title":"Regul Toxicol Pharmacol"},{"issue":"6","key":"10.1016\/j.cld.2022.08.005_bib19","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1111\/acer.12442","article-title":"Validation of blood phosphatidylethanol as an alcohol consumption biomarker in patients with chronic liver disease","volume":"38","author":"Stewart","year":"2014","journal-title":"Alcohol Clin Exp Res"},{"issue":"10","key":"10.1016\/j.cld.2022.08.005_bib20","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1432-2277.2004.tb00395.x","article-title":"Pretransplant screening of sobriety with carbohydrate-deficient transferrin in patients suffering from alcoholic cirrhosis","volume":"17","author":"Berlakovich","year":"2004","journal-title":"Transpl Int"},{"issue":"12","key":"10.1016\/j.cld.2022.08.005_bib21","first-page":"1729","article-title":"Carbohydrate deficient transferrin in abstaining patients with end-stage liver disease","volume":"25","author":"DiMartini","year":"2001","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"10.1016\/j.cld.2022.08.005_bib22","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jhep.2016.08.011","article-title":"The genetics of alcohol dependence and alcohol-related liver disease","volume":"66","author":"Stickel","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2022.08.005_bib23","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jhep.2017.03.031","article-title":"Contribution of alcohol use disorders on the burden of chronic hepatitis C in France, 2008-2013: a nationwide retrospective cohort study","volume":"67","author":"Schwarzinger","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2022.08.005_bib24","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1053\/gast.2002.30992","article-title":"Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis","volume":"122","author":"Fletcher","year":"2002","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cld.2022.08.005_bib25","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.cld.2016.02.004","article-title":"Pathogenesis of alcoholic liver disease","volume":"20","author":"Dunn","year":"2016","journal-title":"Clin Liver Dis"},{"issue":"2","key":"10.1016\/j.cld.2022.08.005_bib26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.5009\/gnl16477","article-title":"Pathophysiology and management of alcoholic liver disease: update 2016","volume":"11","author":"Stickel","year":"2017","journal-title":"Gut Liver"},{"issue":"2","key":"10.1016\/j.cld.2022.08.005_bib27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2021.7683","article-title":"Diagnosis and treatment of alcohol-associated liver disease: a review","volume":"326","author":"Singal","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.cld.2022.08.005_bib28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.21037\/tgh.2019.10.02","article-title":"Clinical presentation of alcoholic liver disease and non-alcoholic fatty liver disease: spectrum and diagnosis","volume":"5","author":"Sharma","year":"2020","journal-title":"Transl Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2022.08.005_bib29","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/jmri.22580","article-title":"Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy","volume":"34","author":"Reeder","year":"2011","journal-title":"J\u00a0Magn Reson Imaging"},{"issue":"3","key":"10.1016\/j.cld.2022.08.005_bib30","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/hep.24452","article-title":"Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis","volume":"54","author":"Hernaez","year":"2011","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2022.08.005_bib31","first-page":"178","article-title":"Current management and future treatment of alcoholic hepatitis","volume":"16","author":"Mitchell","year":"2020","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"9","key":"10.1016\/j.cld.2022.08.005_bib32","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/0003-4819-110-9-685","article-title":"Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial","volume":"110","author":"Carithers","year":"1989","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.cld.2022.08.005_bib33","first-page":"561","article-title":"Current management of alcohol-associated liver disease","volume":"16","author":"Siddiqi","year":"2020","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"4","key":"10.1016\/j.cld.2022.08.005_bib34","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/alcalc\/agz036","article-title":"Alcoholic hepatitis: a review","volume":"54","author":"Hosseini","year":"2019","journal-title":"Alcohol Alcohol"},{"issue":"6","key":"10.1016\/j.cld.2022.08.005_bib35","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.21607","article-title":"The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids","volume":"45","author":"Louvet","year":"2007","journal-title":"Hepatol Jun"},{"issue":"2","key":"10.1016\/j.cld.2022.08.005_bib36","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/ajg.2016.539","article-title":"A\u00a0day-4 Lille model predicts response to corticosteroids and mortality in severe alcoholic hepatitis","volume":"112","author":"Garcia-Saenz-de-Sicilia","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1016\/j.cld.2022.08.005_bib37","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1111\/j.1572-0241.2008.02104.x","article-title":"A\u00a0new scoring system for prognostic stratification of patients with alcoholic hepatitis","volume":"103","author":"Dominguez","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2022.08.005_bib38","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/hep.20503","article-title":"MELD accurately predicts mortality in patients with alcoholic hepatitis","volume":"41","author":"Dunn","year":"2005","journal-title":"Hepatol"},{"issue":"7","key":"10.1016\/j.cld.2022.08.005_bib39","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1111\/j.1572-0241.2008.01837.x","article-title":"Alcohol consumption by cirrhotic subjects: patterns of use and effects on liver function","volume":"103","author":"Lucey","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.cld.2022.08.005_bib40","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1360-0443.2009.02521.x","article-title":"Alcohol-related cirrhosis--early abstinence is a key factor in prognosis, even in the most severe cases","volume":"104","author":"Verrill","year":"2009","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.cld.2022.08.005_bib41","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/apt.12427","article-title":"Determinants of long-term outcome in severe alcoholic hepatitis","volume":"38","author":"Potts","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.cld.2022.08.005_bib42","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/hep.29240","article-title":"Main drivers of outcome differ between short term and long term in severe alcoholic hepatitis: a prospective study","volume":"66","author":"Louvet","year":"2017","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2022.08.005_bib43","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/hep.29338","article-title":"Alcohol abstinence in patients surviving an episode of alcoholic hepatitis: prediction and impact on long-term survival","volume":"66","author":"Altamirano","year":"2017","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.cld.2022.08.005_bib44","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1016\/j.cgh.2020.10.026","article-title":"Provider attitudes and practices for alcohol screening, treatment, and education in patients with liver disease: a survey from the American association for the study of liver diseases alcohol-associated liver disease special interest group","volume":"19","author":"Im","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"19","key":"10.1016\/j.cld.2022.08.005_bib45","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1101214","article-title":"Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis","volume":"365","author":"Nguyen-Khac","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.cld.2022.08.005_bib46","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1053\/j.gastro.2015.06.006","article-title":"Comparative effectiveness of pharmacological interventions for severe alcoholic hepatitis: a systematic review and Network meta-analysis","volume":"149","author":"Singh","year":"2015","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.cld.2022.08.005_bib47","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1111\/liv.12786","article-title":"The use of beta-blockers is associated with the occurrence of acute kidney injury in severe alcoholic hepatitis","volume":"35","author":"Serst\u00e9","year":"2015","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.cld.2022.08.005_bib48","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1053\/j.gastro.2015.12.038","article-title":"Intensive enteral nutrition is ineffective for patients with severe alcoholic hepatitis treated with corticosteroids","volume":"150","author":"Moreno","year":"2016","journal-title":"Gastroenterol Apr"},{"issue":"1","key":"10.1016\/j.cld.2022.08.005_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/nu10010088","article-title":"Associations between zinc deficiency and metabolic abnormalities in patients with chronic liver disease","volume":"10","author":"Himoto","year":"2018","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.cld.2022.08.005_bib50","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1172\/JCI60777","article-title":"IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice","volume":"122","author":"Petrasek","year":"2012","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1016\/j.cld.2022.08.005_bib51","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3350\/cmh.2020.0145","article-title":"Emerging medical therapies for severe alcoholic hepatitis","volume":"26","author":"Tornai","year":"2020","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.cld.2022.08.005_bib52","article-title":"IL-1 receptor antagonist plus pentoxifylline and zinc for severe alcohol-associated hepatitis","volume":"27","author":"Szabo","year":"2022","journal-title":"Hepatol"},{"issue":"8","key":"10.1016\/j.cld.2022.08.005_bib53","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.alcohol.2008.08.006","article-title":"Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study","volume":"42","author":"Kirpich","year":"2008","journal-title":"Alcohol"},{"issue":"1","key":"10.1016\/j.cld.2022.08.005_bib54","doi-asserted-by":"crossref","first-page":"G32","DOI":"10.1152\/ajpgi.00024.2012","article-title":"Lactobacillus rhamnosus GG culture supernatant ameliorates acute alcohol-induced intestinal permeability and liver injury","volume":"303","author":"Wang","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"9","key":"10.1016\/j.cld.2022.08.005_bib55","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.jnutbio.2013.02.001","article-title":"Lactobacillus rhamnosus GG reduces hepatic TNF\u03b1 production and inflammation in chronic alcohol-induced liver injury","volume":"24","author":"Wang","year":"2013","journal-title":"J Nutr Biochem Sep"},{"issue":"4","key":"10.1016\/j.cld.2022.08.005_bib56","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.cgh.2016.10.029","article-title":"Healthy donor fecal microbiota transplantation in steroid-ineligible severe alcoholic hepatitis: a pilot study","volume":"15","author":"Philips","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2022.08.005_bib57","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/hep.22317","article-title":"Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial","volume":"48","author":"Spahr","year":"2008","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.cld.2022.08.005_bib58","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.cgh.2018.01.040","article-title":"Efficacy of granulocyte colony-stimulating factor and N-acetylcysteine therapies in patients with severe alcoholic hepatitis","volume":"16","author":"Singh","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2022.08.005_bib59","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/hep.31046","article-title":"An open-label, dose-escalation study to assess the safety and efficacy of IL-22 agonist F-652 in patients with alcohol-associated hepatitis","volume":"72","author":"Arab","year":"2020","journal-title":"Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2022.08.005_bib60","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jhep.2007.03.027","article-title":"A\u00a0randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis","volume":"47","author":"Stewart","year":"2007","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2022.08.005_bib61","first-page":"17","article-title":"Effects of Metadoxine on cellular status of glutathione and of enzymatic defence system following acute ethanol intoxication in rats","volume":"22","author":"Calabrese","year":"1996","journal-title":"Drugs Exp Clin Res"},{"issue":"3","key":"10.1016\/j.cld.2022.08.005_bib62","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1665-2681(19)30863-4","article-title":"Treatment with metadoxine and its impact on early mortality in patients with severe alcoholic hepatitis","volume":"13","author":"Higuera-de la Tijera","year":"2014","journal-title":"Ann Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2022.08.005_bib63","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1053\/jlts.2000.18497","article-title":"Interpreting the significance of drinking by alcohol-dependent liver transplant patients: fostering candor is the key to recovery","volume":"6","author":"Weinrieb","year":"2000","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.cld.2022.08.005_bib64","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.cld.2012.08.012","article-title":"Evaluation and selection of the patient with alcoholic liver disease for liver transplant","volume":"16","author":"Leong","year":"2012","journal-title":"Clin Liver Dis"},{"issue":"3","key":"10.1016\/j.cld.2022.08.005_bib65","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/lt.500030305","article-title":"Liver transplantation for alcoholic liver disease: a survey of transplantation programs in the United States","volume":"3","author":"Everhart","year":"1997","journal-title":"Liver Transpl Surg"},{"issue":"2","key":"10.1016\/j.cld.2022.08.005_bib66","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1530-0277.1998.tb03681.x","article-title":"A\u00a0model to examine the validity of the 6-month abstinence criterion for liver transplantation","volume":"22","author":"Yates","year":"1998","journal-title":"Alcohol Clin Exp Res"},{"issue":"19","key":"10.1016\/j.cld.2022.08.005_bib67","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa1105703","article-title":"Early liver transplantation for severe alcoholic hepatitis","volume":"365","author":"Mathurin","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.cld.2022.08.005_bib68","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1053\/j.gastro.2018.04.009","article-title":"Outcomes of early liver transplantation for patients with severe alcoholic hepatitis","volume":"155","author":"Lee","year":"2018","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.cld.2022.08.005_bib69","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1176\/appi.ajp.2013.12060782","article-title":"DSM-5 criteria for substance use disorders: recommendations and rationale","volume":"170","author":"Hasin","year":"2013","journal-title":"Am J Psychiatry"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326122000691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326122000691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:59:41Z","timestamp":1761069581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326122000691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S1089326122000691"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2022.08.005","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alcohol-Related Liver Disease Including New Developments","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2022.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}